Genelux Corp. (GNLX) Social Stream
GENELUX CORP (GNLX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering GNLX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-15 | 1 | $10 | $10 | $10 | $13.97 | -28.42% |
| 2023-06-12 | 2 | $25 | $10 | $17.5 | $13.97 | 25.27% |
| 2023-08-14 | 2 | $38 | $25 | $31.5 | $13.97 | 125.48% |
| 2023-10-02 | 3 | $40 | $25 | $34.333 | $13.97 | 145.76% |
| 2023-10-30 | 3 | $40 | $30 | $36 | $13.97 | 157.7% |
| 2023-11-27 | 4 | $40 | $30 | $35.75 | $13.97 | 155.91% |
The Trend in the Analyst Price Target
Over the past 168 days, GNLX's average price target has gone up $16.25.
Over the past 41 weeks, GNLX's average upside potential has been 76%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-15 | 1 | 10 | 10 | 10.000 | 6.445 | 55.16% |
| 2023-06-12 | 2 | 25 | 10 | 17.500 | 29.950 | -41.57% |
| 2023-09-12 | 3 | 40 | 25 | 34.333 | 22.670 | 51.45% |
| 2023-10-30 | 3 | 40 | 30 | 36.000 | 13.860 | 159.74% |
| 2023-11-27 | 4 | 40 | 30 | 35.750 | 10.870 | 228.89% |
GNLX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 153 days, GNLX's average broker recommendation rating improved by 1.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GNLX as an investment opportunity.
- In terms of how GENELUX CORP fares relative to all US stocks, note that its number of analysts covering the stock is higher than 68.3% of that group.
- GENELUX CORP's upside potential (average analyst target price relative to current price) is higher than 650.26% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, GENELUX CORP's variance in analysts' estimates is lower than -97.41% of them.
- In terms of how GENELUX CORP fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 624.26% of that group.
Stocks similar to GENELUX CORP in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MLYS, DYAI, and PHGE.
View All Top Stocks by Price Target
What is the outlook for GNLX? Use POWR Ratings for clearer insight into price direction.